ArticleMetabolism open2021

Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus without established cardiovascular disease: Do they have a role in primary prevention?

Shailaja Kale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.